Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML

Featuring an interview with Dr Eytan Stein, including the following topics: Practical considerations for using venetoclax/HMA (hypomethylating agent) combinations in the management of acute myeloid leukemia (AML) (0:00) Approach to transplant for older patients with AML (10:33) Potential availability of magrolimab and sabatolimab in clinical practice (13:04) ASH 2022 preview: Investigational therapies excluding transplantation and cellular immunotherapies (17:33) Activity, tolerability and future directions with FLT3 and IDH inhibitors in AML (22:29) CME information and select publications